Cargando…

Activity of Exebacase (CF-301) against Biofilms Formed by Staphylococcus epidermidis Strains Isolated from Prosthetic Joint Infections

Staphylococcus epidermidis is one of the main pathogens responsible for bone and joint infections, especially those involving prosthetic materials, due to its ability to form biofilms. In these cases, biofilm formation, combined with increased antimicrobial resistance, often results in therapeutic f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Souche, Aubin, Kolenda, Camille, Teoli, Jordan, Schuch, Raymond, Ferry, Tristan, Laurent, Frédéric, Josse, Jérôme
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2022
Materias:	Experimental Therapeutics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380561/ https://www.ncbi.nlm.nih.gov/pubmed/35861539 http://dx.doi.org/10.1128/aac.00588-22

Ejemplares similares

Arthroscopic “Debridement and Implant Retention” With Local Administration of Exebacase (Lysin CF-301) Followed by Suppressive Tedizolid as Salvage Therapy in Elderly Patients for Relapsing Multidrug-Resistant S. epidermidis Prosthetic Knee Infection
por: Ferry, Tristan, et al.
Publicado: (2021)

712. Activity of Exebacase (CF-301) Against Methicillin-Resistant Staphylococcus aureus (MRSA) Biofilms on Orthopedic Kirschner Wires
por: Karau, Melissa J, et al.
Publicado: (2019)

711. Exebacase (Lysin CF-301) Activity Against Staphylococcus aureus (S. aureus) Isolates From Bacteremic Patients Enrolled in a Phase 2 Study (CF-301-102)
por: Anastasiou, Diane, et al.
Publicado: (2019)

1059. In vitro Activity of Exebacase (CF-301) against Staphylococcus aureus Causing Bacteremia in the United States, Including Multidrug-resistant Subsets
por: Mendes, Rodrigo E, et al.
Publicado: (2021)

1342. Comparison of Lysin CF-301 (Exebacase) Activity Against S. aureus Isolates From Bacteremic Patients Enrolled in a Phase 2 Study (CF-301-102) to Contemporary Surveillance Isolates
por: Anastasiou, Diane, et al.
Publicado: (2018)

Exebacase Is Active In Vitro in Pulmonary Surfactant and Is Efficacious Alone and Synergistic with Daptomycin in a Mouse Model of Lethal Staphylococcus aureus Lung Infection
por: Swift, Steven M., et al.
Publicado: (2021)

1550. PK-PD Relationship and PK Driver of Efficacy of the Novel Antibacterial Lysin Exebacase (CF-301) in Pre-Clinical Models
por: Ghahramani, Parviz, et al.
Publicado: (2019)

Antibiotics in Bone Cements Used for Prosthesis Fixation: An Efficient Way to Prevent Staphylococcus aureus and Staphylococcus epidermidis Prosthetic Joint Infection
por: Cara, Andréa, et al.
Publicado: (2021)

671. Impact of Dose-Administration Strategies of the Antistaphylococcal Lysin Exebacase, (CF-301), in Addition to Daptomycin (DAP) in an Experimental Infective Endocarditis (IE) Model due to Methicillin-Resistant Staphylococcus aureus (MRSA)
por: Xiong, Yan, et al.
Publicado: (2019)

Rapid bacteriolysis of Staphylococcus aureus by lysin exebacase
por: Vila-Farres, Xavier, et al.
Publicado: (2023)

Locally delivered antistaphylococcal lysin exebacase or CF-296 is active in methicillin-resistant Staphylococcus aureus implant-associated osteomyelitis
por: Karau, Melissa, et al.
Publicado: (2022)

In vitro activity of exebacase against methicillin-resistant Staphylococcus aureus biofilms on orthopedic Kirschner wires
por: Karau, Melissa J., et al.
Publicado: (2023)

Lysin CF-301 Demonstrates In Vitro Synergy with Conventional Antibiotics against Staphylococcus aureus
por: Sauve, Karen, et al.
Publicado: (2017)

Past and Future of Phage Therapy and Phage-Derived Proteins in Patients with Bone and Joint Infection
por: Ferry, Tristan, et al.
Publicado: (2021)

Activity of Antistaphylococcal Lysin CF-301 against Contemporary Staphylococcus aureus Clinical Isolates from the USA and Europe
por: Oh, Jun, et al.
Publicado: (2017)

Experience With the Use of the MicroDTTect Device for the Diagnosis of Low-Grade Chronic Prosthetic Joint Infections in a Routine Setting
por: Kolenda, Camille, et al.
Publicado: (2021)

Development of a Broth Microdilution Method for Exebacase Susceptibility Testing
por: Oh, Jun T., et al.
Publicado: (2021)

Staphylococcus epidermidis in Orthopedic Device Infections: The Role of Bacterial Internalization in Human Osteoblasts and Biofilm Formation
por: Valour, Florent, et al.
Publicado: (2013)

The Lysin Exebacase Has a Low Propensity for Resistance Development in Staphylococcus aureus and Suppresses the Emergence of Resistance to Antistaphylococcal Antibiotics
por: Oh, Jun, et al.
Publicado: (2023)

Phage Therapy as Adjuvant to Conservative Surgery and Antibiotics to Salvage Patients With Relapsing S. aureus Prosthetic Knee Infection
por: Ferry, Tristan, et al.
Publicado: (2020)

Adherence ability of Staphylococcus epidermidis on prosthetic biomaterials: an in vitro study
por: Shida, Takayuki, et al.
Publicado: (2013)

Determination of MIC Quality Control Parameters for Exebacase, a Novel Lysin with Antistaphylococcal Activity
por: Traczewski, Maria M., et al.
Publicado: (2021)

Cadmium Modulates Biofilm Formation by Staphylococcus epidermidis
por: Wu, Xueqing, et al.
Publicado: (2015)

Infection Related Glomerulonephritis Associated with Staphylococcus epidermidis in the Absence of Prosthetic Material
por: Mohandes, Samer, et al.
Publicado: (2014)

Adherence ability of Staphylococcus epidermidis on prosthetic biomaterials: an in vitro study [Corrigendum]
Publicado: (2015)

Lavage with Allicin in Combination with Vancomycin Inhibits Biofilm Formation by Staphylococcus epidermidis in a Rabbit Model of Prosthetic Joint Infection
por: Zhai, Haohan, et al.
Publicado: (2014)

Combination Therapy With Lysin CF-301 and Antibiotic Is Superior to Antibiotic Alone for Treating Methicillin-Resistant Staphylococcus aureus–Induced Murine Bacteremia
por: Schuch, Raymond, et al.
Publicado: (2014)

Immune Evasion Mechanisms of Staphylococcus epidermidis Biofilm Infection
por: Le, Katherine Y., et al.
Publicado: (2018)

Induction heating for eradicating Staphylococcus epidermidis from biofilm
por: Pijls, Bart G., et al.
Publicado: (2020)

Inhibitory effects of ultrasound irradiation on Staphylococcus epidermidis biofilm
por: Koibuchi, Harumi, et al.
Publicado: (2021)

Correction of Linezolid-Induced Myelotoxicity After Switch to Tedizolid in a Patient Requiring Suppressive Antimicrobial Therapy for Multidrug-Resistant Staphylococcus epidermidis Prosthetic-Joint Infection
por: Ferry, Tristan, et al.
Publicado: (2018)

Viscoelastic properties of Staphylococcus aureus and Staphylococcus epidermidis mono‐microbial biofilms
por: Di Stefano, Antonio, et al.
Publicado: (2009)

Staphylococcus epidermidis isolates from nares and prosthetic joint infections are mupirocin susceptible
por: Salih, Lavin, et al.
Publicado: (2018)

Heterogeneity of Staphylococcus epidermidis in prosthetic joint infections: time to reevaluate microbiological criteria?
por: Widerström, Micael, et al.
Publicado: (2021)

Antibiotic susceptibility and architecture of Staphylococcis aureus and Staphylococcus epidermidis biofilms
por: Coraca-Huber, DC, et al.
Publicado: (2011)

Inhibition of Staphylococcus epidermidis Biofilms Using Polymerizable Vancomycin Derivatives
por: Lawson, McKinley C., et al.
Publicado: (2010)

Biofilm Formation by Staphylococcus epidermidis on Foldable and Rigid Intraocular Lenses
por: Fazly Bazzaz, Bibi Sedigheh, et al.
Publicado: (2014)

Biofilm extracellular DNA enhances mixed species biofilms of Staphylococcus epidermidis and Candida albicans
por: Pammi, Mohan, et al.
Publicado: (2013)

Non‐biofilm‐forming commensal Staphylococcus epidermidis isolates produce biofilm in the presence of trypsin
por: Martínez‐García, Sergio, et al.
Publicado: (2019)

Nitroxide Functionalized Antibiotics Are Promising Eradication Agents against Staphylococcus aureus Biofilms
por: Verderosa, Anthony D., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dmu7m5tlgcdbf7cp1gr0m35b5c